Transmyocardial laser revascularization in treatment chronic coronary artery disease

Abstract

Perioperative mortality was of 7.4%, long-term follow-up revealed 13.3% mortality, with 50% rate of cardiac associated deaths. MACE-free rate during 10 to 15 years follow-up period amounts 63.3%. General incidence of myocardial infarct (MI) after the procedure accounted for 34.5%. The improvement of the quality of life ascertained by patients was observed in all cases. Patients were we divided into two groups based on whether LAD grafting was (56.7%) or was not (43.3%) performed. In 23.5% cases with LAD graft, TMLR was also applied to the anterior myocardium. Improvement of the quality of life assessed by the EQ-5D scale is higher in patients without LAD grafting (42.5 vs. 31.25) (p = 0.215). Patients with LAD bypass graft benefited lower MI incidence and mortality in long-term follow-up (33.3% vs. 41.7% for MI incidence and 7.7% vs. 23.1% for mortality). Applying TMLR at anterior wall additionally to bypass grafting on LAD resulted in only 25% MI incidence and no deaths in long-term follow-up. Conclusions This study indicates a significant effect on angina relief in patients, who received TMLR, measured by the EQ5D scale. We believe that in patients with end-stage CAD TMLR should be applied as an additional procedure to direct revascularization. Beneficial influence of this combined procedure was confirmed by diminished incidence of MI and death in the long-term follow-up.